Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial
Glund, Stephan, Stangier, Joachim, Schmohl, Michael, Gansser, Dietmar, Norris, Stephen, van Ryn, Joanne, Lang, Benjamin, Ramael, Steven, Moschetti, Viktoria, Gruenenfelder, Fredrik, Reilly, Paul, KreuLanguage:
english
Journal:
The Lancet
DOI:
10.1016/s0140-6736(15)60732-2
Date:
June, 2015
File:
PDF, 398 KB
english, 2015